Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001
| Autor: | Ichihara, Eiki, Hotta, Katsuyuki, Nogami, Naoyuki, Kuyama, Shoichi, Kishino, Daizo, Fujii, Masanori, Kozuki, Toshiyuki, Tabata, Masahiro, Harada, Daijiro, Chikamori, Kenichi, Aoe, Keisuke, Ueoka, Hiroshi, Hosokawa, Shinobu, Bessho, Akihiro, Hisamoto-Sato, Akiko, Kubo, Toshio, Oze, Isao, Takigawa, Nagio, Tanimoto, Mitsune, Kiura, Katsuyuki |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2015 10(3):486-491 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|